Early Diagnosis of Myocardial Infarction with MB-CK Subforms

  • Robert Roberts
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 193)


Caring for patients with acute myocardial infarction (AMI) in a dedicated critical care unit was introduced in 1962 and over the next decade became widespread throughout North America and Europe. There was a significant reduction in mortality from between 30% and 35% to about 20% within 5-6 years of introducing the coronary care unit (CCU). As these results became available and more knowledge accrued of the mechanisms involved with sudden death and cardiac failure, it became the accepted norm for patients with AMI to be admitted to the CCU. However, due to the lack of distinguishing features of chest pain and the lack of diagnostic specificity of the electrocardiogram (ECG), it was often necessary to admit the patient to the CCU to subsequently exclude myocardial infarction. Initially the diagnostic enzymatic markers performed in the CCU consisted of serum glutamic oxaloacetic transaminase (SCOT), lactic dehydrogenase (LDH), and creatine kinase (CK), which were performed daily for 3 days for exclusion of infarction


Acute Myocardial Infarction Creatine Kinase Emergency Room Acute Myocardial Infarction Coronary Care Unit 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Roberts R. Enzymatic diagnosis of acute myocardial infarction. Chest 93:3S, 1988.Google Scholar
  2. 2.
    Roberts R. Diagnostic assessment of myocardial infarction based on lactate dehydrogenase and creatine kinase isoenzymes. Heart Lung 10:486, 1981.PubMedGoogle Scholar
  3. 3.
    Roe CR, Limbird LE, Wagner GS, Nerenberg ST. Combined isoenzyme analysis in the diagnosis of myocardial injury: Application of electrophoretic methods for the detection and the quantitation of the creatine phosphokinase MB isoenzyme. J Lab Clin Med 80:577, 1972.PubMedGoogle Scholar
  4. 4.
    Roberts R. Reperfusion and the plasma isoforms of creatine kinase isoenzymes: A clinical perspective. J Am Coll Cardiol 9:464, 1987.PubMedGoogle Scholar
  5. 5.
    Selker HP. Coronary care unit triage decision aids: How do we know when they work? Am J Med 87:491, 1989.PubMedGoogle Scholar
  6. 6.
    Lee TH, Weisberg MC, Brand DA, Rouan GW, Goldman L. Candidates for thrombolysis among emergency room patients with acute chest pain. Ann Intern Med 110:957, 1989.PubMedGoogle Scholar
  7. 7.
    Weingarten SR, Ermann B, Riedinger MS, Shah PK, Ellrodt G. Selecting the best triage rule tor patients hospitalized with chest pain. Am J Med 87:494, 1989.PubMedCrossRefGoogle Scholar
  8. 8.
    Young MJ, McMahon LF, Stross JK. Prediction rules for patients with suspected myocardial infarction. Arch Intern Med 147:1219, 1987.PubMedCrossRefGoogle Scholar
  9. 9.
    Stark ME, Vacek JL. The initial electrocardiogram during admission for myocardial infarction. Arch Intern Med 47:843, 1987.CrossRefGoogle Scholar
  10. 10.
    Fesmire FM, Percy RF, Wears RL, MacMath TL. Risk stratification according to the initial electrocardiogram in patients with suspected acute myocardial infarction. Arch Intern Med 149:1294, 1989.PubMedCrossRefGoogle Scholar
  11. 11.
    Roberts R. Thrombolysis and its sequelae: Calcium antagonists as potential adjunctive therapy. Circulation 80:IV93, 1989.PubMedGoogle Scholar
  12. 12.
    Brush JE, Brand DA, Acampora D, Chalmer B, Wackers FJ. Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. N Engl J Med 312:1137, 1985.PubMedCrossRefGoogle Scholar
  13. 13.
    Yusuf S, Pearson M, Sterry H. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J 5:690, 1984.PubMedGoogle Scholar
  14. 14.
    Lee TH, Rouan GW, Weisberg MC, Brand DA, Cook EF, Acampora D, Goldman L. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med 106:181, 1987.PubMedGoogle Scholar
  15. 15.
    Lee TH, Juarez G, Cook EF, Weisberg MC, Rouan GW, Brand DA, Goldman L. Ruling out acute myocardial infarction. N Engl J Med 324:1239, 1991.PubMedCrossRefGoogle Scholar
  16. 16.
    Puleo PR, Guadagno PA, Roberts R, Perryman MB. Sensitive, rapid assay of subforms of creatine kinase MB in plasma. Clin Chem 35:1452, 1989.PubMedGoogle Scholar
  17. 17.
    Puleo PR, Guadagno PA, Roberts R, Scheel MV, Marian AJ, Churchill D, Perryman MB. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 82:759, 1990.PubMedGoogle Scholar
  18. 18.
    Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler SH, Hamburg RJ, Ali MN, Obermueller SD, Triana JT, Zimmerman JL, Perryman MB, Roberts R. Use of rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331:561, 1994.PubMedCrossRefGoogle Scholar
  19. 19.
    Delahunty TJ, Forback CC. Automated creatine kinase-MB estimation by immunoinhibition: A clinical evaluation. Clin Chem 26:568, 1980.PubMedGoogle Scholar
  20. 20.
    de Winter RJ, Koster RW, Sturk A, Sanders GT. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 92:3401, 1995.PubMedGoogle Scholar
  21. 21.
    Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 88:101, 1993.PubMedGoogle Scholar
  22. 22.
    Adams JE, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodar GS, Ladenson JH, and Jaffe AS. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 330:670, 1994.PubMedCrossRefGoogle Scholar
  23. 23.
    Perryman MB, Strauss AW, Olson J, Roberts R. In vitro translation of canine mitochondrial creatine kinase from messenger RNA. Biochem Biophys Res Commun 110:967, 1983.PubMedGoogle Scholar
  24. 24.
    Perryman MB, Kerner SA, Bohlmeyer TJ, Roberts R. Isolation and sequence analysis of a full-length cDNA for human M creatine kinase. Biochem Biophys Res Commun 140:981, 1986.PubMedCrossRefGoogle Scholar
  25. 25.
    Villarreal-Levy G, Ma TS, Kerner SA, Roberts R, Perryman MB. Human creatine kinase: Isolation and sequence analysis of cDNA clones for the B subunit, development of subunit specific probes and determination of gene copy number. Biochem Biophys Res Commun 144:1116, 1987.PubMedCrossRefGoogle Scholar
  26. 26.
    Wevers RA, Delsing M, Klein-Gebbink JA, Soons JB. Post-synthetic changes in creatine kinase isoenzymes. Clin Chim Acta 86:323, 1978.PubMedCrossRefGoogle Scholar
  27. 27.
    George S, Ishikawa Y, Perryman MB, Roberrs R. Purification and characterization of naturally occurring and in vitro induced multiple forms of MM creatine kinase. J Biol Chem 259:2667, 1984.PubMedGoogle Scholar
  28. 28.
    Billadello JJ, Fontanet HL, Strauss AW, Abendschein DR. Characterization of MB creatine kinase isoform conversion in vitro and in vivo in dogs. J Clin Invest 83:1637, 1989.PubMedGoogle Scholar
  29. 29.
    Hashimoto H, Abendschein DR, Strauss AW, Sobel BE. Early detection of myocardial infarction in conscious dogs by analysis of plasma MM creatine kinase isoforms. Circulation 71:363, 1985.PubMedGoogle Scholar
  30. 30.
    Jaffe AS, Serota H, Grace A, Sobel BE. Diagnostic-changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction. Circulation 74:105, 1986.PubMedGoogle Scholar
  31. 31.
    Wu AH, Gornet TG, Wu VH, Brockie RE, Nishikawa A. Early diagnosis of acute myocardial infarction by rapid analysis of creatine kinase isoenzyme-3 (CK-MM) subtypes. Clin Chem 33:358, 1987.PubMedGoogle Scholar
  32. 32.
    Grande P, Christiansen C, Pedersen A, Christensen MS. Optimal diagnosis in acute myocardial infarction. A cost effectiveness study. Circulation 61:723, 1980.PubMedGoogle Scholar
  33. 33.
    Klein MS, Shell WE, Sobel BE. Serum creatine phosphokinase (CPK) isoenzymes after intramuscular injections, surgery, and myocardial infarction. Experimental and clinical studies. Cardiovasc Res 7:412, 1973.PubMedCrossRefGoogle Scholar
  34. 34.
    Apple FS, Rogers MA, Ivy JL. Early detection of skeletal muscle injury by assay of creatine kinase MM isoforms in serum after acute exercise. Clin Chem 34:1102, 1988.PubMedGoogle Scholar
  35. 35.
    Apple FS, Rogers MA, Ivy JL. Creatine kinase isoenzyme MM variants in skeletal muscle and plasma from marathon runners. Clin Chem 32:41, 1986.PubMedGoogle Scholar
  36. 36.
    Clarkson PM, Apple FS, Byrnes WC, McCormick KM, Triffletti P. Creatine kinase isoforms following isometric exercise. Muscle Nerve 10:41, 1987.PubMedCrossRefGoogle Scholar
  37. 37.
    Annesley TM, Strongwater SL, Schnitzer TJ. MM subisoenzymes of creatine kinase as an index of disease activity in polymyositis. Clin Chem 31:402, 1985.PubMedGoogle Scholar
  38. 38.
    Henry PD, Roberts R, Sobel BE. Rapid separation of plasma creatine kinase isoenzymes by batch absorption with glass beads. Clin Chem 21:844, 1975.PubMedGoogle Scholar
  39. 39.
    Turi ZG, Rutherford JD, Roberts R, Muller JE, Jaffe AS, Rude RE, Parker C, Raabe DS, Stone PH, Hartwell TD, Lewis SE, Parkey RW, Gold HK, Robertson TL, Sobel BE, Willerson JT, Braunwald E, and the MILIS Study Group. Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (a MILIS Study). Am J Cardiol 55:1463, 1985.PubMedCrossRefGoogle Scholar
  40. 40.
    MILIS Study Group. National Heart, Lung, and Blood Institute Multicenter Investigation of the Limitation of Infarct Size (MILIS): Design and Methods of the Clinical Trial. An Investigation of Beta-Blockade and Hyaluronidase for Treatment of Acute Myocardial Infarction. Dallas, TX: American Heart Association Monograph 100, 1984.Google Scholar
  41. 41.
    Yasmineh WG, Ibrahim GA, Abbasnezhad MA, Awad EA. Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin Chem 24:1985, 1978.PubMedGoogle Scholar
  42. 42.
    Apple FS, Rogers MA, Sherman WM, Costill DL, Hagerman FC, Ivy JL. Profile of creatine kinase isoenzymes in skeletal muscles of marathon runners. Clin Chem 30:413, 1984.PubMedGoogle Scholar
  43. 43.
    Ohman EM, Sigmon KN, Califf RM. Is diagnostic certainty essential for the use of thrombolytic therapy during myocardial infarction in the 1990s? Circulation 82:1073, 1990.PubMedGoogle Scholar
  44. 44.
    Michael LH, Hunt JR, Weilbaecher D, Perryman MB, Roberts R, Lewis RM, Entman ML. Creatine kinase and phosphorylase in cardiac lymph: Coronary occlusion and reperfusion. Am J Physiol 17:H350, 1985.Google Scholar
  45. 45.
    Heyndrickx GR, Amano J, Kenna T, Fallon JT, Patrick TA, Manders WT, Rogers GG, Rosendorff C, Vatner SF. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 6:1299, 1985.PubMedCrossRefGoogle Scholar
  46. 46.
    Ishikawa Y, Saffitz JE, Mealman JE, Grace AM, Roberts R. Reversible myocardial ischemic injury is not associated with increased creatine kinase activites in plasma. Clin Chem 43:467, 1997.PubMedGoogle Scholar
  47. 47.
    Grenadier E, Keidar S, Kahana L, Alpan G, Marmor A, Palant A. The roles of serum myoglobin, total CPK, and CK-MB isoenzyme in the acute phase of myocardial infarction. Am Heart J 105:408, 1983.PubMedCrossRefGoogle Scholar
  48. 48.
    Bhayana V, Henderson AR. Evaluation of cardio-REP for creatine kinase isoforms analaysis (abstr). Clin Chem 4l:S184, 1995.Google Scholar
  49. 49.
    Plebani M, Secchiero S, Altinier S, Lachin M, Sciacovelli L. Evaluation of a new automated system for CK-MB isoforms determination (abstr). Clin Chem 41:S174, 1995.Google Scholar
  50. 50.
    Snow JS, Cohen MB, Morrison J, Ward M, Sama AE, Ryan JG, Tria L, Syn T. CK-MB isoforms as a marker of myocadial infarction (abstr). J Investig Med 43:313, 1995.Google Scholar
  51. 51.
    Cannon CP, Walls RM. Editorial: Waiting for godot: Use of chemical markers in the emergency department evaluation of chest pain. J Emerg Med 13:533, 1995.PubMedCrossRefGoogle Scholar
  52. 52.
    Roberts R, From R, Beaudreaux A, Zimmerman J, Meyer D, Wun C, Davis B, Smallings R, Habib G. Multi-center blinded trial utilizing multiple diagnostic markers to exclude myocardial infarction in patients presenting consecutively to the ER with chest pain (abstr). Circulation 94:1, 1996.Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Robert Roberts

There are no affiliations available

Personalised recommendations